Steigerwald Gordon & Koch Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$2.84M |
| 2 |
Apple
AAPL
|
+$556K |
| 3 |
Stryker
SYK
|
+$504K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$464K |
| 5 |
Amgen
AMGN
|
+$419K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$1.23M |
| 2 |
BorgWarner
BWA
|
+$950K |
| 3 |
CACI
CACI
|
+$777K |
| 4 |
Kinder Morgan
KMI
|
+$386K |
| 5 |
AB InBev
BUD
|
+$384K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 16.48% |
| 3 | Communication Services | 11.71% |
| 4 | Energy | 9.42% |
| 5 | Financials | 8.66% |
Similar funds
Steigerwald Gordon & Koch's Q4 2016 Portfolio in Review
As of Q4 2016, Steigerwald Gordon & Koch held 88 positions worth $314M, up 9.1% from $287M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Steigerwald Gordon & Koch deployed $9.97M of net new capital in Q4 2016, opening 17 new positions and adding to 41 existing holdings. Its largest new stake was CDK Global, Inc.: 49,576 shares worth $2.92M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was NextGen Healthcare, Inc. Common Stock, an estimated $1.23M trimmed.
- Steigerwald Gordon & Koch's largest Q4 2016 buy was CDK Global, Inc.: 49,576 shares worth $2.92M.
- Steigerwald Gordon & Koch added most to Apple in Q4 2016, an estimated $556K increase.
- Steigerwald Gordon & Koch's biggest Q4 2016 reduction was NextGen Healthcare, Inc. Common Stock, cutting an estimated $1.23M.
- Steigerwald Gordon & Koch fully exited AB InBev in Q4 2016, selling an estimated $384K.
- Steigerwald Gordon & Koch's ten largest holdings make up 30% of its $314M portfolio in Q4 2016.
- Steigerwald Gordon & Koch opened 17 new positions and closed 3 in Q4 2016.
- Steigerwald Gordon & Koch's portfolio value rose 9.1% quarter-over-quarter to $314M.
Based on Steigerwald Gordon & Koch's 13F filing for Q4 2016, filed 13 Sep 2018.